Connecting industry, physicians, and staff in unprecedented times.
This resource has been made possible with support from industry sponsors.
Latest News
07.19.21
FDA Sets January Deadline to Decide on Full Approval of Pfizer, BioNTech VaccineSource: FirstWord
07.09.21
Pfizer Plans to Seek FDA Nod for COVID-19 Booster Next Month as Delta SpreadsSource: FirstWord
07.08.21
Cognivue Initiates Nationwide Clinical Study to Assess Post-COVID-19 Syndrome (Long Haul Syndrome)Source: Cognivue
07.07.21
Ocugen Climbs on Phase 3 COVID Vaccine Data, Hitting Back at Delta VariantSource: FierceBiotech
07.01.21
Oyster Point Announces Preclinical Data Highlighting Potent Activity of OC-01 and OC-02 Against SARS-CoV-2 Virus and VariantsSource: Oyster Point Pharma
06.25.21
Roche’s Actemra Gains FDA Emergency-Use in Hospitalized COVID-19 PatientsSource: FirstWord
06.18.21
US Looks to Spur Advances in COVID-19 Antivirals With $3.2-Billion InfusionSource: FirstWord
06.15.21
Two Shots of Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Delta Variant: StudySource: FiercePharma
06.11.21
OcuGen to No Longer Pursue EUA for Covid-19 Vaccine Candidate Covaxin; Will Pursue Full ApprovalSource: Ocugen
06.11.21
US to Buy 500 Million Doses of Pfizer, BioNTech COVID-19 Vaccine for Donation to Poorest NationsSource: FirstWord
05.24.21
Study Finds Pfizer, AstraZeneca’s COVID-19 Vaccines “Highly Effective” Against Indian VariantSource: FirstWord
05.21.21
EU Signs Deal With BioNTech, Pfizer for Further 1.8 Billion COVID-19 Vaccine DosesSource: FirstWord